CD56 marks human dendritic cell subsets with cytotoxic potential

by Roothans, Dessie, Smits, Evelien, Lion, Eva, Tel, Jurjen, Anguille, Sébastien
Published 2013

Naturally circulating dendritic cells to vaccinate cancer patients

by Bol, Kalijn F., Tel, Jurjen, de Vries, I. Jolanda M., Figdor, Carl G.
Published 2013

Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity

by Tel, Jurjen, Benitez-Ribas, Daniel, Janssen, Edith M., Smits, Evelien L. J., Jacobs, Joannes F. M.
Published 2016

Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells

by Eggermont, Loek J., Paulis, Leonie E., Tel, Jurjen, Figdor, Carl G.
Published 2014

Harnessing human plasmacytoid dendritic cells as professional APCs

by Tel, Jurjen, van der Leun, Anne M., Figdor, Carl G., Torensma, Ruurd, de Vries, I. Jolanda M.
Published 2012

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues

by Tel, Jurjen, Hato, Stanleyson V., Torensma, Ruurd, Buschow, Sonja I., Figdor, Carl G., Lesterhuis, W. Joost, de Vries, I. Jolanda M.
Published 2011

Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential

by Anguille, Sébastien, Lion, Eva, Tel, Jurjen, de Vries, I. Jolanda M, Couderé, Karen, Fromm, Phillip D., Van Tendeloo, Viggo F., Smits, Evelien L., Berneman, Zwi N.
Published 2012

Correction: Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential

by Anguille, Sébastien, Lion, Eva, Tel, Jurjen, de Vries, I. Jolanda M, Couderé, Karen, Fromm, Phillip D., Van Tendeloo, Viggo F., Smits, Evelien L., Berneman, Zwi N.
Published 2014

Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses

by Dölen, Yusuf, Kreutz, Martin, Gileadi, Uzi, Tel, Jurjen, Vasaturo, Angela, van Dinther, Eric A. W., van Hout-Kuijer, Maaike A., Cerundolo, Vincenzo, Figdor, Carl G.
Published 2015

Long-lasting multifunctional CD8+ T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination

by Wimmers, Florian, Aarntzen, Erik H. J. G., Duiveman-deBoer, Tjitske, Figdor, Carl G., Jacobs, Joannes F. M., Tel, Jurjen, de Vries, I. Jolanda M.
Published 2015

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets

by Sittig, Simone P., Bakdash, Ghaith, Weiden, Jorieke, Sköld, Annette E., Tel, Jurjen, Figdor, Carl G., de Vries, I. Jolanda M., Schreibelt, Gerty
Published 2016

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets

by Sköld, Annette E., van Beek, Jasper J. P., Sittig, Simone P., Bakdash, Ghaith, Tel, Jurjen, Schreibelt, Gerty, de Vries, I. Jolanda M.
Published 2015

Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition

by Tel, Jurjen, Koornstra, Rutger, de Haas, Nienke, van Deutekom, Vincent, Westdorp, Harm, Boudewijns, Steve, van Erp, Nielka, Di Blasio, Stefania, Gerritsen, Winald, Figdor, Carl G., de Vries, I. Jolanda M., Hato, Stanleyson V.
Published 2016

Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function

by Worah, Kuntal, Mathan, Till S.M., Vu Manh, Thien Phong, Keerthikumar, Shivakumar, Schreibelt, Gerty, Tel, Jurjen, Duiveman-de Boer, Tjitske, Sköld, Annette E., van Spriel, Annemiek B., de Vries, I. Jolanda M., Huynen, Martijn A., Wessels, Hans J., Gloerich, Jolein, Dalod, Marc, Lasonder, Edwin, Figdor, Carl G., Buschow, Sonja I.
Published 2016